BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2518686)

  • 1. Transformation suppressor genes.
    Noda M; Kitayama H; Kanazawa S; Murata S; Matsuzaki T; Ikawa Y
    Princess Takamatsu Symp; 1989; 20():233-9. PubMed ID: 2518686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of the K-rev-1 transformation-suppressor gene.
    Kitayama H; Matsuzaki T; Sugimoto Y; Ikawa Y; Noda M
    Environ Health Perspect; 1991 Jun; 93():73-7. PubMed ID: 1773804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations.
    Kitayama H; Matsuzaki T; Ikawa Y; Noda M
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4284-8. PubMed ID: 2112251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion and rereversion in ras-transformed cells.
    Marshall CJ
    Immunol Ser; 1990; 51():89-106. PubMed ID: 2128917
    [No Abstract]   [Full Text] [Related]  

  • 8. The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells.
    Kondoh N; Noda M; Fisher RJ; Schweinfest CW; Papas TS; Kondoh A; Samuel KP; Oikawa T
    Biochim Biophys Acta; 1996 Aug; 1313(1):41-6. PubMed ID: 8781548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region.
    Pizon V; Chardin P; Lerosey I; Olofsson B; Tavitian A
    Oncogene; 1988 Aug; 3(2):201-4. PubMed ID: 3045729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of amino acid residues required for Ras p21 target activation.
    Marshall MS; Davis LJ; Keys RD; Mosser SD; Hill WS; Scolnick EM; Gibbs JB
    Mol Cell Biol; 1991 Aug; 11(8):3997-4004. PubMed ID: 1906576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of GTPases and GTPase regulatory proteins in oncogenesis.
    Grunicke HH; Maly K
    Crit Rev Oncog; 1993; 4(4):389-402. PubMed ID: 8353139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
    Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
    Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cDNA clone with anti-oncogene activity.
    Liu DG; Wang D; Chen ZZ; Li ZP; Makoto N; Yoji I
    Sci China B; 1992 Jul; 35(7):822-33. PubMed ID: 1449605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human Krev-1 gene in lungs of transgenic mice and subsequent reduction in multiplicity of ethyl carbamate-induced lung adenomas.
    Damak S; Harnboonsong Y; George PM; Bullock DW
    Mol Carcinog; 1996 Oct; 17(2):84-91. PubMed ID: 8890957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor.
    Whitehead I; Kirk H; Kay R
    Oncogene; 1995 Feb; 10(4):713-21. PubMed ID: 7862449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
    Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
    Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.
    Wolthuis RM; Bauer B; van 't Veer LJ; de Vries-Smits AM; Cool RH; Spaargaren M; Wittinghofer A; Burgering BM; Bos JL
    Oncogene; 1996 Jul; 13(2):353-62. PubMed ID: 8710374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A domain responsible for the transformation suppressor activity in Krev-1 protein.
    Kitayama H; Matsuzaki T; Ikawa Y; Noda M
    Jpn J Cancer Res; 1990 May; 81(5):445-8. PubMed ID: 2116391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.